Clinical trial of weekly paclitaxel chemotherapy for papillary thyroid carcinoma with squamous cell carcinoma component
Author:
Affiliation:
1. Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan
2. Department of Pathology, Kuma Hospital, Kobe 650-0011, Japan
Publisher
Japan Endocrine Society
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
https://www.jstage.jst.go.jp/article/endocrj/59/9/59_EJ12-0174/_pdf
Reference22 articles.
1. Primary Squamous Cell Carcinoma of the Thyroid: Report of Three Cases
2. 2. DeLellis RA, Lloyd RV, Heitz P, Eng C (2004) Pathology and Genetics of Tumours of Endocrine Organs, Lyon, IARC Press.
3. 3. Bronner MP, LiVolsi VA (1991) Spindle cell squamous carcinoma of the thyroid: an unusual anaplastic tumor associated with tall cell papillary cancer. Mod Pathol 4: 637-643.
4. 4. Kleer CG, Giordano TJ, Merino MJ (2000) Squamous cell carcinoma of the thyroid: an aggressive tumor associated with tall cell variant of papillary thyroid carcinoma. Mod Pathol 13: 742-746.
5. 5. Saunders CA, Nayar R (2000) Anaplastic spindle-cell squamous carcinoma arising in association with tall-cell papillary cancer of the thyroid: A potential pitfall. Diagn Cytopathol 22: 136-138.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Neoadjuvant Multikinase Inhibitor Therapy in Locally Advanced Unresectable Differentiated Thyroid Carcinoma: a Case Report;Indian Journal of Surgery;2022-12-14
2. Ultrasound-targeted microbubble destruction-mediated miR-144-5p overexpression enhances the anti-tumor effect of paclitaxel on thyroid carcinoma by targeting STON2;Cell Cycle;2022-02-20
3. Programmed cell death, redox imbalance, and cancer therapeutics;Apoptosis;2021-07-08
4. Long-term efficacy of weekly paclitaxel therapy in unresectable primary squamous cell carcinoma of the thyroid;Auris Nasus Larynx;2021-07
5. Herbal Active Ingredients: An Emerging Potential for the Prevention and Treatment of Papillary Thyroid Carcinoma;BioMed Research International;2020-01-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3